An Observational Pilot Study Evaluating the Feasibility of Conducting Genome-Wide Association Studies Utilizing Subject Provided Information in Subjects With Locally Recurrent or MBC, MCRC, MNSCLC, RGBM or MRCC Treated With Avastin (Bevacizumab) (InVite)
Status: COMPLETED
Study type: OBSERVATIONAL
Conditions: Breast Cancer|Colorectal Cancer|Non-Small Cell Lung Cancer|Glioblastoma|Renal Cell Cancer
Sponsor: Genentech, Inc.
Collaborators: 23andMe, Inc.